HRMY
Closed
Harmony Biosciences Holdings
32.03
+0.43 (+1.36%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 31.6
Day's Range: 31.82 - 33.69
Send
sign up or login to leave a comment!
When Written:
33.03
Harmony Biosciences Holdings, Inc. is a biopharmaceutical company based in Plymouth Meeting, Pennsylvania. The company is focused on developing and commercializing innovative therapies for people living with rare neurological disorders. Harmony's first product, WAKIX® (pitolisant), was approved by the U.S. Food and Drug Administration (FDA) in 2019 for the treatment of excessive daytime sleepiness (EDS) in adult patients with narcolepsy. The company is also developing a pipeline of novel therapies for other rare neurological conditions, including idiopathic hypersomnia, REM sleep behavior disorder, and narcolepsy in pediatric patients. Harmony Biosciences Holdings, Inc. was founded in 2017 and went public in 2020.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








